nodes	percent_of_prediction	percent_of_DWPC	metapath
Oxandrolone—Progesterone—uterine cancer	0.419	1	CrCtD
Oxandrolone—AR—Medroxyprogesterone Acetate—uterine cancer	0.143	0.602	CbGbCtD
Oxandrolone—AR—Progesterone—uterine cancer	0.0945	0.398	CbGbCtD
Oxandrolone—Trilostane—Progesterone—uterine cancer	0.0353	0.119	CrCrCtD
Oxandrolone—Stanozolol—Progesterone—uterine cancer	0.0295	0.0996	CrCrCtD
Oxandrolone—Drostanolone—Progesterone—uterine cancer	0.0255	0.086	CrCrCtD
Oxandrolone—Spironolactone—Medroxyprogesterone Acetate—uterine cancer	0.0222	0.0747	CrCrCtD
Oxandrolone—Formestane—Progesterone—uterine cancer	0.0214	0.072	CrCrCtD
Oxandrolone—Spironolactone—Progesterone—uterine cancer	0.0193	0.0651	CrCrCtD
Oxandrolone—Danazol—Progesterone—uterine cancer	0.0163	0.055	CrCrCtD
Oxandrolone—Norethindrone—Progesterone—uterine cancer	0.0142	0.0478	CrCrCtD
Oxandrolone—Fluoxymesterone—Medroxyprogesterone Acetate—uterine cancer	0.0141	0.0474	CrCrCtD
Oxandrolone—Testosterone Propionate—Medroxyprogesterone Acetate—uterine cancer	0.0137	0.0462	CrCrCtD
Oxandrolone—Progesterone—Medroxyprogesterone Acetate—uterine cancer	0.0137	0.0462	CrCrCtD
Oxandrolone—Methyltestosterone—Medroxyprogesterone Acetate—uterine cancer	0.0134	0.045	CrCrCtD
Oxandrolone—Fluoxymesterone—Progesterone—uterine cancer	0.0123	0.0413	CrCrCtD
Oxandrolone—Testosterone Propionate—Progesterone—uterine cancer	0.0119	0.0403	CrCrCtD
Oxandrolone—Testosterone—Medroxyprogesterone Acetate—uterine cancer	0.0119	0.0401	CrCrCtD
Oxandrolone—Methyltestosterone—Progesterone—uterine cancer	0.0116	0.0393	CrCrCtD
Oxandrolone—Testosterone—Progesterone—uterine cancer	0.0104	0.035	CrCrCtD
Oxandrolone—AR—semen—uterine cancer	0.00371	0.263	CbGeAlD
Oxandrolone—Glucose tolerance decreased—Progesterone—uterine cancer	0.00296	0.116	CcSEcCtD
Oxandrolone—AR—oviduct—uterine cancer	0.00272	0.193	CbGeAlD
Oxandrolone—Glucose tolerance decreased—Medroxyprogesterone Acetate—uterine cancer	0.00269	0.105	CcSEcCtD
Oxandrolone—Menstruation irregular—Progesterone—uterine cancer	0.00107	0.0421	CcSEcCtD
Oxandrolone—Hirsutism—Progesterone—uterine cancer	0.00102	0.0401	CcSEcCtD
Oxandrolone—Hepatic necrosis—Progesterone—uterine cancer	0.00102	0.0401	CcSEcCtD
Oxandrolone—Menstruation irregular—Medroxyprogesterone Acetate—uterine cancer	0.000974	0.0381	CcSEcCtD
Oxandrolone—Hirsutism—Medroxyprogesterone Acetate—uterine cancer	0.000928	0.0363	CcSEcCtD
Oxandrolone—AR—myometrium—uterine cancer	0.000871	0.0618	CbGeAlD
Oxandrolone—Oligospermia—Epirubicin—uterine cancer	0.000814	0.0319	CcSEcCtD
Oxandrolone—Oligospermia—Doxorubicin—uterine cancer	0.000753	0.0295	CcSEcCtD
Oxandrolone—Acne—Progesterone—uterine cancer	0.000707	0.0277	CcSEcCtD
Oxandrolone—Necrosis—Medroxyprogesterone Acetate—uterine cancer	0.000687	0.0269	CcSEcCtD
Oxandrolone—AR—epithelium—uterine cancer	0.000683	0.0485	CbGeAlD
Oxandrolone—AR—uterine cervix—uterine cancer	0.000678	0.0481	CbGeAlD
Oxandrolone—Jaundice cholestatic—Progesterone—uterine cancer	0.000677	0.0265	CcSEcCtD
Oxandrolone—AR—smooth muscle tissue—uterine cancer	0.000659	0.0467	CbGeAlD
Oxandrolone—AR—decidua—uterine cancer	0.000646	0.0458	CbGeAlD
Oxandrolone—Acne—Medroxyprogesterone Acetate—uterine cancer	0.000641	0.0251	CcSEcCtD
Oxandrolone—AR—renal system—uterine cancer	0.000634	0.045	CbGeAlD
Oxandrolone—Azoospermia—Epirubicin—uterine cancer	0.000633	0.0248	CcSEcCtD
Oxandrolone—Jaundice cholestatic—Medroxyprogesterone Acetate—uterine cancer	0.000613	0.024	CcSEcCtD
Oxandrolone—AR—endometrium—uterine cancer	0.000613	0.0435	CbGeAlD
Oxandrolone—AR—mammalian vulva—uterine cancer	0.000593	0.042	CbGeAlD
Oxandrolone—Azoospermia—Doxorubicin—uterine cancer	0.000586	0.0229	CcSEcCtD
Oxandrolone—AR—uterus—uterine cancer	0.000565	0.0401	CbGeAlD
Oxandrolone—Fluid retention—Progesterone—uterine cancer	0.000565	0.0221	CcSEcCtD
Oxandrolone—Neoplasm—Progesterone—uterine cancer	0.000538	0.0211	CcSEcCtD
Oxandrolone—Necrosis—Dactinomycin—uterine cancer	0.000536	0.021	CcSEcCtD
Oxandrolone—Fluid retention—Medroxyprogesterone Acetate—uterine cancer	0.000512	0.02	CcSEcCtD
Oxandrolone—AR—female reproductive system—uterine cancer	0.000508	0.036	CbGeAlD
Oxandrolone—Neoplasm—Medroxyprogesterone Acetate—uterine cancer	0.000487	0.0191	CcSEcCtD
Oxandrolone—AR—female gonad—uterine cancer	0.000462	0.0328	CbGeAlD
Oxandrolone—AR—vagina—uterine cancer	0.000459	0.0326	CbGeAlD
Oxandrolone—AR—Coregulation of Androgen receptor activity—PAWR—uterine cancer	0.000448	0.0914	CbGpPWpGaD
Oxandrolone—Irritability—Progesterone—uterine cancer	0.000412	0.0161	CcSEcCtD
Oxandrolone—Necrosis—Etoposide—uterine cancer	0.000388	0.0152	CcSEcCtD
Oxandrolone—Irritability—Medroxyprogesterone Acetate—uterine cancer	0.000373	0.0146	CcSEcCtD
Oxandrolone—Blood creatinine increased—Medroxyprogesterone Acetate—uterine cancer	0.000367	0.0143	CcSEcCtD
Oxandrolone—Haemoglobin—Progesterone—uterine cancer	0.0003	0.0118	CcSEcCtD
Oxandrolone—Haemorrhage—Progesterone—uterine cancer	0.000299	0.0117	CcSEcCtD
Oxandrolone—AR—lymph node—uterine cancer	0.000297	0.0211	CbGeAlD
Oxandrolone—Haemoglobin—Medroxyprogesterone Acetate—uterine cancer	0.000272	0.0106	CcSEcCtD
Oxandrolone—Haemorrhage—Medroxyprogesterone Acetate—uterine cancer	0.000271	0.0106	CcSEcCtD
Oxandrolone—Allylestrenol—PGR—uterine cancer	0.000264	0.12	CrCbGaD
Oxandrolone—Trilostane—ESR2—uterine cancer	0.000264	0.12	CrCbGaD
Oxandrolone—AR—Nuclear Receptors—PGR—uterine cancer	0.000232	0.0473	CbGpPWpGaD
Oxandrolone—Danazol—CCL2—uterine cancer	0.000218	0.0988	CrCbGaD
Oxandrolone—Necrosis—Epirubicin—uterine cancer	0.000217	0.00851	CcSEcCtD
Oxandrolone—Oedema—Progesterone—uterine cancer	0.000212	0.00831	CcSEcCtD
Oxandrolone—AR—Nuclear Receptors—ESR2—uterine cancer	0.000204	0.0417	CbGpPWpGaD
Oxandrolone—Necrosis—Doxorubicin—uterine cancer	0.000201	0.00787	CcSEcCtD
Oxandrolone—Jaundice cholestatic—Epirubicin—uterine cancer	0.000194	0.0076	CcSEcCtD
Oxandrolone—Oedema—Medroxyprogesterone Acetate—uterine cancer	0.000192	0.00753	CcSEcCtD
Oxandrolone—Insomnia—Progesterone—uterine cancer	0.000192	0.00751	CcSEcCtD
Oxandrolone—AR—Nuclear Receptor transcription pathway—PGR—uterine cancer	0.000184	0.0374	CbGpPWpGaD
Oxandrolone—Jaundice cholestatic—Doxorubicin—uterine cancer	0.00018	0.00703	CcSEcCtD
Oxandrolone—Creatinine increased—Epirubicin—uterine cancer	0.000179	0.00701	CcSEcCtD
Oxandrolone—Insomnia—Medroxyprogesterone Acetate—uterine cancer	0.000174	0.00681	CcSEcCtD
Oxandrolone—AR—Integrated Pancreatic Cancer Pathway—MAP3K4—uterine cancer	0.000169	0.0345	CbGpPWpGaD
Oxandrolone—Drostanolone—CYP19A1—uterine cancer	0.000168	0.0765	CrCbGaD
Oxandrolone—Allylestrenol—ESR1—uterine cancer	0.000167	0.0757	CrCbGaD
Oxandrolone—Creatinine increased—Doxorubicin—uterine cancer	0.000166	0.00649	CcSEcCtD
Oxandrolone—Trilostane—ESR1—uterine cancer	0.000163	0.0738	CrCbGaD
Oxandrolone—Fluid retention—Epirubicin—uterine cancer	0.000162	0.00634	CcSEcCtD
Oxandrolone—AR—Nuclear Receptor transcription pathway—ESR2—uterine cancer	0.000162	0.0329	CbGpPWpGaD
Oxandrolone—Neoplasm—Epirubicin—uterine cancer	0.000154	0.00604	CcSEcCtD
Oxandrolone—Oedema—Dactinomycin—uterine cancer	0.00015	0.00587	CcSEcCtD
Oxandrolone—Fluid retention—Doxorubicin—uterine cancer	0.00015	0.00586	CcSEcCtD
Oxandrolone—Neoplasm—Doxorubicin—uterine cancer	0.000143	0.00559	CcSEcCtD
Oxandrolone—Danazol—PGR—uterine cancer	0.000133	0.0602	CrCbGaD
Oxandrolone—Spironolactone—PGR—uterine cancer	0.000127	0.0577	CrCbGaD
Oxandrolone—AR—Nuclear Receptors—ESR1—uterine cancer	0.000124	0.0253	CbGpPWpGaD
Oxandrolone—AR—Regulation of nuclear beta catenin signaling and target gene transcription—YWHAE—uterine cancer	0.000122	0.0249	CbGpPWpGaD
Oxandrolone—Norethindrone—PGR—uterine cancer	0.000118	0.0536	CrCbGaD
Oxandrolone—Blood creatinine increased—Epirubicin—uterine cancer	0.000116	0.00454	CcSEcCtD
Oxandrolone—AR—Integrated Breast Cancer Pathway—MSH6—uterine cancer	0.000111	0.0226	CbGpPWpGaD
Oxandrolone—AR—FOXA1 transcription factor network—ESR1—uterine cancer	0.00011	0.0225	CbGpPWpGaD
Oxandrolone—Blood creatinine increased—Doxorubicin—uterine cancer	0.000107	0.0042	CcSEcCtD
Oxandrolone—AR—Nuclear Receptor transcription pathway—ESR1—uterine cancer	9.8e-05	0.02	CbGpPWpGaD
Oxandrolone—AR—Integrated Pancreatic Cancer Pathway—INHBA—uterine cancer	9.45e-05	0.0193	CbGpPWpGaD
Oxandrolone—Danazol—CYP19A1—uterine cancer	9.1e-05	0.0413	CrCbGaD
Oxandrolone—AR—Regulation of nuclear SMAD2/3 signaling—CDKN2B—uterine cancer	9.09e-05	0.0185	CbGpPWpGaD
Oxandrolone—AR—Integrated Breast Cancer Pathway—MSH2—uterine cancer	9.01e-05	0.0184	CbGpPWpGaD
Oxandrolone—Fluoxymesterone—ESR1—uterine cancer	8.76e-05	0.0398	CrCbGaD
Oxandrolone—Testosterone—CYP11A1—uterine cancer	8.62e-05	0.0391	CrCbGaD
Oxandrolone—Haemoglobin—Epirubicin—uterine cancer	8.61e-05	0.00337	CcSEcCtD
Oxandrolone—Haemorrhage—Epirubicin—uterine cancer	8.57e-05	0.00335	CcSEcCtD
Oxandrolone—Danazol—ESR1—uterine cancer	8.37e-05	0.038	CrCbGaD
Oxandrolone—AR—Regulation of nuclear SMAD2/3 signaling—SMAD3—uterine cancer	8.3e-05	0.0169	CbGpPWpGaD
Oxandrolone—Haemoglobin—Doxorubicin—uterine cancer	7.97e-05	0.00312	CcSEcCtD
Oxandrolone—Haemorrhage—Doxorubicin—uterine cancer	7.93e-05	0.0031	CcSEcCtD
Oxandrolone—AR—Androgen receptor signaling pathway—SMAD3—uterine cancer	7.69e-05	0.0157	CbGpPWpGaD
Oxandrolone—Methyltestosterone—CYP19A1—uterine cancer	7.69e-05	0.0349	CrCbGaD
Oxandrolone—AR—FOXA1 transcription factor network—CDKN1B—uterine cancer	7.5e-05	0.0153	CbGpPWpGaD
Oxandrolone—AR—SIDS Susceptibility Pathways—YWHAE—uterine cancer	7.16e-05	0.0146	CbGpPWpGaD
Oxandrolone—AR—Notch-mediated HES/HEY network—CDKN1B—uterine cancer	7.11e-05	0.0145	CbGpPWpGaD
Oxandrolone—Progesterone—PGR—uterine cancer	6.88e-05	0.0312	CrCbGaD
Oxandrolone—AR—Regulation of nuclear SMAD2/3 signaling—ESR1—uterine cancer	6.77e-05	0.0138	CbGpPWpGaD
Oxandrolone—AR—SIDS Susceptibility Pathways—ESR2—uterine cancer	6.61e-05	0.0135	CbGpPWpGaD
Oxandrolone—AR—FOXA1 transcription factor network—EP300—uterine cancer	6.58e-05	0.0134	CbGpPWpGaD
Oxandrolone—AR—Coregulation of Androgen receptor activity—CDKN2A—uterine cancer	6.52e-05	0.0133	CbGpPWpGaD
Oxandrolone—AR—Nongenotropic Androgen signaling—PIK3CA—uterine cancer	6.45e-05	0.0131	CbGpPWpGaD
Oxandrolone—AR—Notch-mediated HES/HEY network—EP300—uterine cancer	6.25e-05	0.0127	CbGpPWpGaD
Oxandrolone—AR—Integrated Breast Cancer Pathway—CYP19A1—uterine cancer	6.16e-05	0.0125	CbGpPWpGaD
Oxandrolone—AR—Integrated Breast Cancer Pathway—STK11—uterine cancer	6.16e-05	0.0125	CbGpPWpGaD
Oxandrolone—Oedema—Epirubicin—uterine cancer	6.09e-05	0.00238	CcSEcCtD
Oxandrolone—AR—Integrated Pancreatic Cancer Pathway—EZH2—uterine cancer	6.06e-05	0.0124	CbGpPWpGaD
Oxandrolone—AR—Nongenotropic Androgen signaling—HRAS—uterine cancer	5.96e-05	0.0122	CbGpPWpGaD
Oxandrolone—AR—Regulation of nuclear beta catenin signaling and target gene transcription—CDH1—uterine cancer	5.95e-05	0.0121	CbGpPWpGaD
Oxandrolone—AR—Regulation of Androgen receptor activity—EP300—uterine cancer	5.67e-05	0.0116	CbGpPWpGaD
Oxandrolone—Oedema—Doxorubicin—uterine cancer	5.63e-05	0.0022	CcSEcCtD
Oxandrolone—AR—Integrated Pancreatic Cancer Pathway—ESR2—uterine cancer	5.62e-05	0.0115	CbGpPWpGaD
Oxandrolone—Insomnia—Epirubicin—uterine cancer	5.5e-05	0.00215	CcSEcCtD
Oxandrolone—AR—Coregulation of Androgen receptor activity—CTNNB1—uterine cancer	5.45e-05	0.0111	CbGpPWpGaD
Oxandrolone—AR—Nongenotropic Androgen signaling—AKT1—uterine cancer	5.27e-05	0.0107	CbGpPWpGaD
Oxandrolone—AR—Regulation of nuclear beta catenin signaling and target gene transcription—CDKN2A—uterine cancer	5.25e-05	0.0107	CbGpPWpGaD
Oxandrolone—AR—Integrated Pancreatic Cancer Pathway—STK11—uterine cancer	5.1e-05	0.0104	CbGpPWpGaD
Oxandrolone—Insomnia—Doxorubicin—uterine cancer	5.09e-05	0.00199	CcSEcCtD
Oxandrolone—AR—Regulation of nuclear beta catenin signaling and target gene transcription—CXCL8—uterine cancer	4.76e-05	0.0097	CbGpPWpGaD
Oxandrolone—AR—Integrated Pancreatic Cancer Pathway—CDKN2B—uterine cancer	4.57e-05	0.00932	CbGpPWpGaD
Oxandrolone—Testosterone—CYP19A1—uterine cancer	4.46e-05	0.0202	CrCbGaD
Oxandrolone—AR—Regulation of nuclear beta catenin signaling and target gene transcription—CTNNB1—uterine cancer	4.39e-05	0.00895	CbGpPWpGaD
Oxandrolone—Progesterone—ESR1—uterine cancer	4.34e-05	0.0197	CrCbGaD
Oxandrolone—AR—Gene Expression—PHF1—uterine cancer	4.3e-05	0.00877	CbGpPWpGaD
Oxandrolone—AR—Integrated Breast Cancer Pathway—ESR1—uterine cancer	4.11e-05	0.00838	CbGpPWpGaD
Oxandrolone—AR—Regulation of nuclear beta catenin signaling and target gene transcription—EP300—uterine cancer	4.08e-05	0.00832	CbGpPWpGaD
Oxandrolone—AR—Regulation of nuclear SMAD2/3 signaling—EP300—uterine cancer	4.04e-05	0.00823	CbGpPWpGaD
Oxandrolone—AR—Androgen receptor signaling pathway—CTNNB1—uterine cancer	4.03e-05	0.00822	CbGpPWpGaD
Oxandrolone—AR—Androgen receptor signaling pathway—PTEN—uterine cancer	3.93e-05	0.00801	CbGpPWpGaD
Oxandrolone—AR—Androgen receptor signaling pathway—EP300—uterine cancer	3.75e-05	0.00764	CbGpPWpGaD
Oxandrolone—AR—Gene Expression—CHD4—uterine cancer	3.66e-05	0.00745	CbGpPWpGaD
Oxandrolone—AR—Integrated Breast Cancer Pathway—CDH1—uterine cancer	3.58e-05	0.00729	CbGpPWpGaD
Oxandrolone—AR—Integrated Pancreatic Cancer Pathway—ESR1—uterine cancer	3.41e-05	0.00695	CbGpPWpGaD
Oxandrolone—AR—Generic Transcription Pathway—PGR—uterine cancer	3.17e-05	0.00646	CbGpPWpGaD
Oxandrolone—AR—Gene Expression—SUZ12—uterine cancer	3.07e-05	0.00625	CbGpPWpGaD
Oxandrolone—AR—Coregulation of Androgen receptor activity—AKT1—uterine cancer	3.06e-05	0.00624	CbGpPWpGaD
Oxandrolone—AR—Generic Transcription Pathway—ESR2—uterine cancer	2.79e-05	0.00569	CbGpPWpGaD
Oxandrolone—AR—SIDS Susceptibility Pathways—CXCL8—uterine cancer	2.79e-05	0.00568	CbGpPWpGaD
Oxandrolone—AR—Integrated Breast Cancer Pathway—CTNNB1—uterine cancer	2.64e-05	0.00538	CbGpPWpGaD
Oxandrolone—AR—Integrated Breast Cancer Pathway—PTEN—uterine cancer	2.57e-05	0.00525	CbGpPWpGaD
Oxandrolone—AR—SIDS Susceptibility Pathways—CTNNB1—uterine cancer	2.57e-05	0.00524	CbGpPWpGaD
Oxandrolone—AR—Integrated Pancreatic Cancer Pathway—ERBB2—uterine cancer	2.5e-05	0.0051	CbGpPWpGaD
Oxandrolone—AR—Integrated Breast Cancer Pathway—EP300—uterine cancer	2.46e-05	0.005	CbGpPWpGaD
Oxandrolone—AR—Regulation of nuclear SMAD2/3 signaling—AKT1—uterine cancer	2.44e-05	0.00498	CbGpPWpGaD
Oxandrolone—AR—SIDS Susceptibility Pathways—EP300—uterine cancer	2.39e-05	0.00487	CbGpPWpGaD
Oxandrolone—AR—Integrated Breast Cancer Pathway—VEGFA—uterine cancer	2.33e-05	0.00474	CbGpPWpGaD
Oxandrolone—AR—Integrated Pancreatic Cancer Pathway—CDKN1B—uterine cancer	2.32e-05	0.00472	CbGpPWpGaD
Oxandrolone—AR—Generic Transcription Pathway—CDKN2B—uterine cancer	2.27e-05	0.00463	CbGpPWpGaD
Oxandrolone—AR—SIDS Susceptibility Pathways—VEGFA—uterine cancer	2.27e-05	0.00462	CbGpPWpGaD
Oxandrolone—AR—Androgen receptor signaling pathway—AKT1—uterine cancer	2.26e-05	0.00461	CbGpPWpGaD
Oxandrolone—AR—Integrated Pancreatic Cancer Pathway—CTNNB1—uterine cancer	2.19e-05	0.00446	CbGpPWpGaD
Oxandrolone—AR—Integrated Pancreatic Cancer Pathway—PTEN—uterine cancer	2.13e-05	0.00435	CbGpPWpGaD
Oxandrolone—AR—Generic Transcription Pathway—SMAD3—uterine cancer	2.07e-05	0.00423	CbGpPWpGaD
Oxandrolone—AR—Integrated Pancreatic Cancer Pathway—EP300—uterine cancer	2.03e-05	0.00415	CbGpPWpGaD
Oxandrolone—AR—Integrated Breast Cancer Pathway—KRAS—uterine cancer	1.98e-05	0.00403	CbGpPWpGaD
Oxandrolone—AR—Integrated Pancreatic Cancer Pathway—VEGFA—uterine cancer	1.93e-05	0.00393	CbGpPWpGaD
Oxandrolone—AR—Integrated Breast Cancer Pathway—TP53—uterine cancer	1.76e-05	0.00358	CbGpPWpGaD
Oxandrolone—AR—Generic Transcription Pathway—ESR1—uterine cancer	1.69e-05	0.00345	CbGpPWpGaD
Oxandrolone—AR—Integrated Pancreatic Cancer Pathway—KRAS—uterine cancer	1.64e-05	0.00334	CbGpPWpGaD
Oxandrolone—AR—Gene Expression—PGR—uterine cancer	1.53e-05	0.00311	CbGpPWpGaD
Oxandrolone—AR—Integrated Pancreatic Cancer Pathway—PIK3CA—uterine cancer	1.5e-05	0.00307	CbGpPWpGaD
Oxandrolone—AR—Integrated Breast Cancer Pathway—AKT1—uterine cancer	1.48e-05	0.00302	CbGpPWpGaD
Oxandrolone—AR—Integrated Pancreatic Cancer Pathway—TP53—uterine cancer	1.46e-05	0.00297	CbGpPWpGaD
Oxandrolone—AR—Gene Expression—EZH2—uterine cancer	1.45e-05	0.00295	CbGpPWpGaD
Oxandrolone—AR—Gene Expression—ESR2—uterine cancer	1.34e-05	0.00274	CbGpPWpGaD
Oxandrolone—AR—Integrated Pancreatic Cancer Pathway—AKT1—uterine cancer	1.23e-05	0.00251	CbGpPWpGaD
Oxandrolone—AR—Gene Expression—CDKN2B—uterine cancer	1.09e-05	0.00223	CbGpPWpGaD
Oxandrolone—AR—Gene Expression—SMAD3—uterine cancer	9.99e-06	0.00204	CbGpPWpGaD
Oxandrolone—AR—Gene Expression—ESR1—uterine cancer	8.15e-06	0.00166	CbGpPWpGaD
Oxandrolone—AR—Gene Expression—AKT1—uterine cancer	2.94e-06	0.000599	CbGpPWpGaD
